{"id":470505,"date":"2021-04-04T17:13:07","date_gmt":"2021-04-04T21:13:07","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=470505"},"modified":"2021-04-04T17:13:07","modified_gmt":"2021-04-04T21:13:07","slug":"important-investor-reminder-kessler-topaz-meltzer-check-llp-reminds-cytodyn-inc-investors-of-deadline-in-securities-fraud-class-action-lawsuit","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/important-investor-reminder-kessler-topaz-meltzer-check-llp-reminds-cytodyn-inc-investors-of-deadline-in-securities-fraud-class-action-lawsuit\/","title":{"rendered":"Important Investor Reminder:  Kessler Topaz Meltzer &amp; Check, LLP Reminds CytoDyn Inc. Investors of Deadline in Securities Fraud Class Action Lawsuit"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">RADNOR, Pa., April  04, 2021  (GLOBE NEWSWIRE) &#8212; The law firm of Kessler Topaz Meltzer &amp; Check, LLP reminds CytoDyn Inc. (OTCMKTS: CYDY) (\u201cCytoDyn\u201d) investors that a securities fraud class action lawsuit has been filed in the United States District Court for the Western District of Washington against CytoDyn on behalf of those who purchased or acquired CytoDyn common stock <strong><em>between March 27, 2020 and March 9, 2021<\/em><\/strong>, inclusive (the \u201cClass Period\u201d).<\/p>\n<p align=\"justify\">\n        <strong><br \/>\n          <em>Lead Plaintiff Deadline: <\/em><br \/>\n        <\/strong><br \/>\n        <strong><br \/>\n          <em><br \/>\n            <u>May 17, 2021<\/u><br \/>\n          <\/em><br \/>\n        <\/strong><br \/>\n        <u>\ufeff<\/u>\ufeff<\/p>\n<table style=\"border-collapse: collapse;width:100%;border-collapse:collapse\">\n<tr>\n<td style=\"max-width:15%;width:15%;min-width:15%;text-align: left;vertical-align: middle;vertical-align: top\">\n            <em><br \/>\n              <strong>Website:<\/strong><br \/>\n            <\/em>\n          <\/td>\n<td style=\"max-width:85%;width:85%;min-width:85%;text-align: left;vertical-align: middle;vertical-align: top\">\n            <a href=\"https:\/\/www.ktmc.com\/cytodyn-class-action-lawsuit?utm_source=PR&amp;utm_medium=link&amp;utm_campaign=cytodyn\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">https:\/\/www.ktmc.com\/cytodyn-class-action-lawsuit?utm_source=PR&amp;utm_medium=link&amp;utm_campaign=cytodyn<\/a>\n          <\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: left;vertical-align: middle;vertical-align: top\">\u00a0<\/td>\n<td style=\"text-align: left;vertical-align: middle;vertical-align: top\">\u00a0<\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: left;vertical-align: middle;vertical-align: top\">\n            <strong><br \/>\n              <em>Contact:<\/em><br \/>\n            <\/strong>\u00a0<\/td>\n<td style=\"text-align: left;vertical-align: middle;vertical-align: top\">\n            <strong>James Maro, Esq. (484) 270-1453<\/strong>\n          <\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: left;vertical-align: middle;vertical-align: top\">\u00a0<\/td>\n<td style=\"text-align: left;vertical-align: middle;vertical-align: top\">\n            <strong>Adrienne Bell, Esq. (484) 270-1435<\/strong>\n          <\/td>\n<\/tr>\n<tr>\n<td style=\"text-align: left;vertical-align: middle;vertical-align: top\">\u00a0<\/td>\n<td style=\"text-align: left;vertical-align: middle;vertical-align: top\">\n            <strong>Toll free (844) 887-9500<\/strong>\n          <\/td>\n<\/tr>\n<\/table>\n<p align=\"justify\">CytoDyn is a biotechnology company that has focused on the development and commercialization of a drug named \u201cLeronlimab\u201d which has long been promoted as a potential therapy for HIV patients. Since the beginning of the global COVID-19 pandemic, CytoDyn began aggressively touting Leronlimab as a treatment for COVID-19.<\/p>\n<p align=\"justify\">The complaint alleges that, throughout the Class Period, the defendants made false and\/or misleading statements and\/or failed to disclose that CytoDyn\u2019s development and marketing of Leronlimab as a treatment for COVID-19 was not commercially viable.<\/p>\n<p align=\"justify\">CytoDyn investors may, <strong><em><u>no later than May 17, 2021<\/u><\/em><\/strong>, seek to be appointed as a lead plaintiff representative of the class through Kessler Topaz Meltzer &amp; Check, LLP, or other counsel, or may choose to do nothing and remain an absent class member.\u00a0 A lead plaintiff is a representative party who acts on behalf of all class members in directing the litigation.\u00a0 In order to be appointed as a lead plaintiff, the Court must determine that the class member\u2019s claim is typical of the claims of other class members, and that the class member will adequately represent the class.\u00a0 Your ability to share in any recovery is not affected by the decision of whether or not to serve as a lead plaintiff.\u00a0<\/p>\n<p align=\"justify\">Kessler Topaz Meltzer &amp; Check, LLP prosecutes class actions in state and federal courts throughout the country involving securities fraud, breaches of fiduciary duties and other violations of state and federal law. Kessler Topaz Meltzer &amp; Check, LLP is a driving force behind corporate governance reform, and has recovered billions of dollars on behalf of institutional and individual investors from the United States and around the world. \u00a0The firm represents investors, consumers and whistleblowers (private citizens who report fraudulent practices against the government and share in the recovery of government dollars).\u00a0 The complaint in this action was not filed by Kessler Topaz Meltzer &amp; Check, LLP. For more information about Kessler Topaz Meltzer &amp; Check, LLP please visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=9JVxCFF4JZKxp3stfHI-uGlSvgXQJrOOuOFInpx4Vg9wGmw42xV8tT_1SYFB73GL18Xleob_sYaVkVMHCnQNVg==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">www.ktmc.com<\/a>.<\/p>\n<p>CONTACT:<\/p>\n<p>Kessler Topaz Meltzer &amp; Check, LLP<br \/>James Maro, Jr., Esq.<br \/>Adrienne Bell, Esq.<br \/>280 King of Prussia Road<br \/>Radnor, PA 19087<br \/>(844) 887-9500 (toll free)<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=oOeqgKk_mC1eOGOupWz5a8vfVVp-IoNykXriMCs3F6qJtc2Q3oTQEJkKFHZCfbe59jRteWV2bU9fFHpyQPGj9w==\" rel=\"nofollow noopener noreferrer\" target=\"_blank\">info@ktmc.com<\/a><\/p>\n<\/p>\n<p>      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIxMDQ4OSM0MTAzMDgxIzIwMTkzMTI=\" width=\"1\" height=\"1\" \/><br \/>\n      <br \/>\n      <img loading=\"lazy\" decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/ml.globenewswire.com\/release\/track\/ae6df4c4-b7d1-4cef-9714-50a373218d01\" width=\"1\" height=\"1\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>RADNOR, Pa., April 04, 2021 (GLOBE NEWSWIRE) &#8212; The law firm of Kessler Topaz Meltzer &amp; Check, LLP reminds CytoDyn Inc. (OTCMKTS: CYDY) (\u201cCytoDyn\u201d) investors that a securities fraud class action lawsuit has been filed in the United States District Court for the Western District of Washington against CytoDyn on behalf of those who purchased or acquired CytoDyn common stock between March 27, 2020 and March 9, 2021, inclusive (the \u201cClass Period\u201d). Lead Plaintiff Deadline: May 17, 2021 \ufeff\ufeff Website: https:\/\/www.ktmc.com\/cytodyn-class-action-lawsuit?utm_source=PR&amp;utm_medium=link&amp;utm_campaign=cytodyn \u00a0 \u00a0 Contact: \u00a0 James Maro, Esq. (484) 270-1453 \u00a0 Adrienne Bell, Esq. (484) 270-1435 \u00a0 Toll free (844) 887-9500 CytoDyn is a biotechnology company that has focused on the development and commercialization of a drug named \u201cLeronlimab\u201d which &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/important-investor-reminder-kessler-topaz-meltzer-check-llp-reminds-cytodyn-inc-investors-of-deadline-in-securities-fraud-class-action-lawsuit\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Important Investor Reminder:  Kessler Topaz Meltzer &amp; Check, LLP Reminds CytoDyn Inc. Investors of Deadline in Securities Fraud Class Action Lawsuit&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-470505","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Important Investor Reminder: Kessler Topaz Meltzer &amp; Check, LLP Reminds CytoDyn Inc. Investors of Deadline in Securities Fraud Class Action Lawsuit - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/important-investor-reminder-kessler-topaz-meltzer-check-llp-reminds-cytodyn-inc-investors-of-deadline-in-securities-fraud-class-action-lawsuit\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Important Investor Reminder: Kessler Topaz Meltzer &amp; Check, LLP Reminds CytoDyn Inc. Investors of Deadline in Securities Fraud Class Action Lawsuit - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"RADNOR, Pa., April 04, 2021 (GLOBE NEWSWIRE) &#8212; The law firm of Kessler Topaz Meltzer &amp; Check, LLP reminds CytoDyn Inc. (OTCMKTS: CYDY) (\u201cCytoDyn\u201d) investors that a securities fraud class action lawsuit has been filed in the United States District Court for the Western District of Washington against CytoDyn on behalf of those who purchased or acquired CytoDyn common stock between March 27, 2020 and March 9, 2021, inclusive (the \u201cClass Period\u201d). Lead Plaintiff Deadline: May 17, 2021 \ufeff\ufeff Website: https:\/\/www.ktmc.com\/cytodyn-class-action-lawsuit?utm_source=PR&amp;utm_medium=link&amp;utm_campaign=cytodyn \u00a0 \u00a0 Contact: \u00a0 James Maro, Esq. (484) 270-1453 \u00a0 Adrienne Bell, Esq. (484) 270-1435 \u00a0 Toll free (844) 887-9500 CytoDyn is a biotechnology company that has focused on the development and commercialization of a drug named \u201cLeronlimab\u201d which &hellip; Continue reading &quot;Important Investor Reminder: Kessler Topaz Meltzer &amp; Check, LLP Reminds CytoDyn Inc. Investors of Deadline in Securities Fraud Class Action Lawsuit&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/important-investor-reminder-kessler-topaz-meltzer-check-llp-reminds-cytodyn-inc-investors-of-deadline-in-securities-fraud-class-action-lawsuit\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2021-04-04T21:13:07+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIxMDQ4OSM0MTAzMDgxIzIwMTkzMTI=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/important-investor-reminder-kessler-topaz-meltzer-check-llp-reminds-cytodyn-inc-investors-of-deadline-in-securities-fraud-class-action-lawsuit\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/important-investor-reminder-kessler-topaz-meltzer-check-llp-reminds-cytodyn-inc-investors-of-deadline-in-securities-fraud-class-action-lawsuit\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Important Investor Reminder: Kessler Topaz Meltzer &amp; Check, LLP Reminds CytoDyn Inc. Investors of Deadline in Securities Fraud Class Action Lawsuit\",\"datePublished\":\"2021-04-04T21:13:07+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/important-investor-reminder-kessler-topaz-meltzer-check-llp-reminds-cytodyn-inc-investors-of-deadline-in-securities-fraud-class-action-lawsuit\\\/\"},\"wordCount\":472,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/important-investor-reminder-kessler-topaz-meltzer-check-llp-reminds-cytodyn-inc-investors-of-deadline-in-securities-fraud-class-action-lawsuit\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODIxMDQ4OSM0MTAzMDgxIzIwMTkzMTI=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/important-investor-reminder-kessler-topaz-meltzer-check-llp-reminds-cytodyn-inc-investors-of-deadline-in-securities-fraud-class-action-lawsuit\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/important-investor-reminder-kessler-topaz-meltzer-check-llp-reminds-cytodyn-inc-investors-of-deadline-in-securities-fraud-class-action-lawsuit\\\/\",\"name\":\"Important Investor Reminder: Kessler Topaz Meltzer &amp; Check, LLP Reminds CytoDyn Inc. Investors of Deadline in Securities Fraud Class Action Lawsuit - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/important-investor-reminder-kessler-topaz-meltzer-check-llp-reminds-cytodyn-inc-investors-of-deadline-in-securities-fraud-class-action-lawsuit\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/important-investor-reminder-kessler-topaz-meltzer-check-llp-reminds-cytodyn-inc-investors-of-deadline-in-securities-fraud-class-action-lawsuit\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODIxMDQ4OSM0MTAzMDgxIzIwMTkzMTI=\",\"datePublished\":\"2021-04-04T21:13:07+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/important-investor-reminder-kessler-topaz-meltzer-check-llp-reminds-cytodyn-inc-investors-of-deadline-in-securities-fraud-class-action-lawsuit\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/important-investor-reminder-kessler-topaz-meltzer-check-llp-reminds-cytodyn-inc-investors-of-deadline-in-securities-fraud-class-action-lawsuit\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/important-investor-reminder-kessler-topaz-meltzer-check-llp-reminds-cytodyn-inc-investors-of-deadline-in-securities-fraud-class-action-lawsuit\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODIxMDQ4OSM0MTAzMDgxIzIwMTkzMTI=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODIxMDQ4OSM0MTAzMDgxIzIwMTkzMTI=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/important-investor-reminder-kessler-topaz-meltzer-check-llp-reminds-cytodyn-inc-investors-of-deadline-in-securities-fraud-class-action-lawsuit\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Important Investor Reminder: Kessler Topaz Meltzer &amp; Check, LLP Reminds CytoDyn Inc. Investors of Deadline in Securities Fraud Class Action Lawsuit\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Important Investor Reminder: Kessler Topaz Meltzer &amp; Check, LLP Reminds CytoDyn Inc. Investors of Deadline in Securities Fraud Class Action Lawsuit - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/important-investor-reminder-kessler-topaz-meltzer-check-llp-reminds-cytodyn-inc-investors-of-deadline-in-securities-fraud-class-action-lawsuit\/","og_locale":"en_US","og_type":"article","og_title":"Important Investor Reminder: Kessler Topaz Meltzer &amp; Check, LLP Reminds CytoDyn Inc. Investors of Deadline in Securities Fraud Class Action Lawsuit - Market Newsdesk","og_description":"RADNOR, Pa., April 04, 2021 (GLOBE NEWSWIRE) &#8212; The law firm of Kessler Topaz Meltzer &amp; Check, LLP reminds CytoDyn Inc. (OTCMKTS: CYDY) (\u201cCytoDyn\u201d) investors that a securities fraud class action lawsuit has been filed in the United States District Court for the Western District of Washington against CytoDyn on behalf of those who purchased or acquired CytoDyn common stock between March 27, 2020 and March 9, 2021, inclusive (the \u201cClass Period\u201d). Lead Plaintiff Deadline: May 17, 2021 \ufeff\ufeff Website: https:\/\/www.ktmc.com\/cytodyn-class-action-lawsuit?utm_source=PR&amp;utm_medium=link&amp;utm_campaign=cytodyn \u00a0 \u00a0 Contact: \u00a0 James Maro, Esq. (484) 270-1453 \u00a0 Adrienne Bell, Esq. (484) 270-1435 \u00a0 Toll free (844) 887-9500 CytoDyn is a biotechnology company that has focused on the development and commercialization of a drug named \u201cLeronlimab\u201d which &hellip; Continue reading \"Important Investor Reminder: Kessler Topaz Meltzer &amp; Check, LLP Reminds CytoDyn Inc. Investors of Deadline in Securities Fraud Class Action Lawsuit\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/important-investor-reminder-kessler-topaz-meltzer-check-llp-reminds-cytodyn-inc-investors-of-deadline-in-securities-fraud-class-action-lawsuit\/","og_site_name":"Market Newsdesk","article_published_time":"2021-04-04T21:13:07+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIxMDQ4OSM0MTAzMDgxIzIwMTkzMTI=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/important-investor-reminder-kessler-topaz-meltzer-check-llp-reminds-cytodyn-inc-investors-of-deadline-in-securities-fraud-class-action-lawsuit\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/important-investor-reminder-kessler-topaz-meltzer-check-llp-reminds-cytodyn-inc-investors-of-deadline-in-securities-fraud-class-action-lawsuit\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Important Investor Reminder: Kessler Topaz Meltzer &amp; Check, LLP Reminds CytoDyn Inc. Investors of Deadline in Securities Fraud Class Action Lawsuit","datePublished":"2021-04-04T21:13:07+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/important-investor-reminder-kessler-topaz-meltzer-check-llp-reminds-cytodyn-inc-investors-of-deadline-in-securities-fraud-class-action-lawsuit\/"},"wordCount":472,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/important-investor-reminder-kessler-topaz-meltzer-check-llp-reminds-cytodyn-inc-investors-of-deadline-in-securities-fraud-class-action-lawsuit\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIxMDQ4OSM0MTAzMDgxIzIwMTkzMTI=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/important-investor-reminder-kessler-topaz-meltzer-check-llp-reminds-cytodyn-inc-investors-of-deadline-in-securities-fraud-class-action-lawsuit\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/important-investor-reminder-kessler-topaz-meltzer-check-llp-reminds-cytodyn-inc-investors-of-deadline-in-securities-fraud-class-action-lawsuit\/","name":"Important Investor Reminder: Kessler Topaz Meltzer &amp; Check, LLP Reminds CytoDyn Inc. Investors of Deadline in Securities Fraud Class Action Lawsuit - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/important-investor-reminder-kessler-topaz-meltzer-check-llp-reminds-cytodyn-inc-investors-of-deadline-in-securities-fraud-class-action-lawsuit\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/important-investor-reminder-kessler-topaz-meltzer-check-llp-reminds-cytodyn-inc-investors-of-deadline-in-securities-fraud-class-action-lawsuit\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIxMDQ4OSM0MTAzMDgxIzIwMTkzMTI=","datePublished":"2021-04-04T21:13:07+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/important-investor-reminder-kessler-topaz-meltzer-check-llp-reminds-cytodyn-inc-investors-of-deadline-in-securities-fraud-class-action-lawsuit\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/important-investor-reminder-kessler-topaz-meltzer-check-llp-reminds-cytodyn-inc-investors-of-deadline-in-securities-fraud-class-action-lawsuit\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/important-investor-reminder-kessler-topaz-meltzer-check-llp-reminds-cytodyn-inc-investors-of-deadline-in-securities-fraud-class-action-lawsuit\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIxMDQ4OSM0MTAzMDgxIzIwMTkzMTI=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODIxMDQ4OSM0MTAzMDgxIzIwMTkzMTI="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/important-investor-reminder-kessler-topaz-meltzer-check-llp-reminds-cytodyn-inc-investors-of-deadline-in-securities-fraud-class-action-lawsuit\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Important Investor Reminder: Kessler Topaz Meltzer &amp; Check, LLP Reminds CytoDyn Inc. Investors of Deadline in Securities Fraud Class Action Lawsuit"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/470505","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=470505"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/470505\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=470505"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=470505"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=470505"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}